SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

Nov 4 2022
BOSTON and LAUSANNE, Switzerland, Nov. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today the company will be participating in the following investor conferences. Evercore ISI HealthCONx Virtual Conference;

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Subject Matter Expert - APAC Malaysia. Singapore Clinical Sales
Senior Director, Clinical & BioPharma Operations Switzerland Medical
Sr Manager, Genomic Implementation Solutions United States Clinical Sales
Deal Desk and Commercial Operations Manager Switzerland. United States Clinical Sales
Events and Marketing Communications Manager United States Marketing & Communications